Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
Actual shortage: | 241 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-KETOCONAZOLE | 200MG | TABLET | Resolved | 2021-01-22 | 2021-09-02 | 132261 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-01-22 | 2021-04-21 | 132264 |
TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132267 |
OXALIPLATIN INJECTION | 5MG | SOLUTION | Resolved | 2021-01-22 | 2021-03-18 | 132270 |
TEVA-PRAZOSIN | 1MG | TABLET | Resolved | 2021-01-22 | 2021-03-11 | 132273 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
TEVA-TEMOZOLOMIDE | 5MG | CAPSULE | Resolved | 2021-01-22 | 2021-06-03 | 132279 |
TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132285 |
TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132288 |
ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132291 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Resolved | 2021-01-22 | 2021-02-12 | 132294 |
ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132297 |
FENTORA | 200MCG | TABLET (EFFERVESCENT) | Resolved | 2021-01-28 | 2021-02-05 | 132630 |
TEVA-PROGESTERONE | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-03-18 | 132633 |
TEVA-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-28 | 2021-02-05 | 132639 |
TREANDA | 100MG | POWDER FOR SOLUTION | Resolved | 2021-01-28 | 2021-02-11 | 132644 |
TEVA-TOPIRAMATE | 100MG | TABLET | Resolved | 2021-01-28 | 2021-02-11 | 132649 |
ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
TEVA-CANDESARTAN/HCTZ | 32MG 12.5MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132657 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-02-13 | 2020-02-13 | 106148 |
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
ACT RANITIDINE | 150MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115079 |
ACT RANITIDINE | 300MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115082 |
TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |
TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |